HK$110.50
3.95% today
Hong Kong, Oct 24, 10:08 am CET
ISIN
CNE1000031K4
Symbol
2359
Index

WuXi AppTec Stock price

HK$110.50
+1.30 1.19% 1M
+53.08 92.45% 6M
+54.52 97.39% YTD
+61.01 123.27% 1Y
+51.00 85.72% 3Y
+16.46 17.50% 5Y
+81.85 285.75% 10Y
+81.85 285.75% 20Y
Hong Kong, Closing price Fri, Oct 24 2025
+4.20 3.95%

Key metrics

Basic
Market capitalization
HK$319.4b
Enterprise Value
HK$304.0b
Net debt
positive
Cash
HK$27.4b
Shares outstanding
2.9b
Valuation (TTM | estimate)
P/E
20.3 | 20.1
P/S
6.8 | 6.6
EV/Sales
6.5 | 6.3
EV/FCF
27.1
P/B
4.9
Dividends
DPS
HK$1.81
Yield 1Y | 5Y
1.0% | 0.9%
Growth 1Y | 5Y
-2.2% | 28.2%
Payout 1Y | 3Y
50.7% | 38.0%
Increased
5 Years
Financials (TTM | estimate)
Revenue
HK$46.7b | HK$48.3b
EBITDA
- | HK$20.0b
EBIT
HK$13.2b | HK$16.5b
Net Income
HK$15.0b | HK$15.2b
Free Cash Flow
HK$11.2b
Growth (TTM | estimate)
Revenue
10.6% | 12.8%
EBITDA
- | 64.0%
EBIT
14.3% | 36.0%
Net Income
61.4% | 47.4%
Free Cash Flow
26.2%
Margin (TTM | estimate)
Gross
43.0%
EBITDA
- | 41.5%
EBIT
28.4%
Net
32.2% | 31.5%
Free Cash Flow
24.0%
Financial Health
Equity Ratio
73.0%
Return on Equity
16.1%
ROCE
19.2%
ROIC
20.5%
Debt/Equity
0.2
More
EPS
HK$5.2
FCF per Share
HK$3.9
Short interest
-
Employees
39k
Rev per Employee
HK$1.1m
Show more

Is WuXi AppTec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.

WuXi AppTec Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a WuXi AppTec forecast:

22x Buy
92%
2x Hold
8%

Analyst Opinions

24 Analysts have issued a WuXi AppTec forecast:

Buy
92%
Hold
8%

Financial data from WuXi AppTec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
46,674 46,674
11% 11%
100%
- Direct Costs 26,597 26,597
5% 5%
57%
20,077 20,077
19% 19%
43%
- Selling and Administrative Expenses 4,437 4,437
9% 9%
10%
- Research and Development Expense 1,218 1,218
21% 21%
3%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 13,245 13,245
14% 14%
28%
Net Profit 15,018 15,018
61% 61%
32%

In millions HKD.

Don't miss a Thing! We will send you all news about WuXi AppTec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.

Head office China
CEO Min Chen
Employees 39,414
Founded 2000
Website www.wuxiapptec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today